Tuesday, July 05, 2022 9:57:16 AM
Item 1.01 Entry into a Material Definitive Agreement.
On June 28, 2020, MamaMancini’s Holdings, Inc. (the “Company”), a marketer and distributor of specialty pre-prepared all-natural foods signed a definitive agreement to acquire a 24 percent (24%) minority interest in Chef Inspirational Foods, Inc. (“CIF”), a leading developer, innovator, marketer and sales company selling fresh and frozen prepared foods, for an investment of $1.2 million, at an implied enterprise value for CIF of $5 million. The investment consists of $500,000 in cash and $700,000 in MamaMancini’s common stock.
The Company also was granted the option to purchase the remaining seventy-six percent (76%) interest in CIF within one year of June 28, 2022. The option purchase price is an additional $3.8 million, of which $3.5 million would be paid in cash and $300,000 in common stock, which would be paid within a two-year period from June 28, 2022.
Founded in 2008, CIF sells fresh and frozen prepared foods for the supermarket, club store, and distributor trade across the United States. The company’s specialty is the Deli Department for prepared salads, prepared entrees and olives, with a unique line of different artisan flavors and styles. CIF is based in West Palm Beach, Florida, and Long Island, NY.
My posts are based solely on my opinion.
Recent MMMB News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/24/2024 08:10:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2024 08:05:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/09/2024 09:18:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 10:05:45 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 12/19/2023 09:45:39 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/18/2023 09:05:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/12/2023 09:16:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:06:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:37:07 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/27/2023 08:36:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:05:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:05:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:04:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:03:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:03:01 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:00:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:00:37 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 09:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/12/2023 06:19:18 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/05/2023 09:12:02 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM